Search research articles
Contact Us
Filters
Showing results (211-220 of 245) with videos related to
Page
of 25
Sort By:
Nature Medicine
|
February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
Maddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Journal of Clinical Immunology
|
July 29, 2021
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
Hasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2019
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Victoria Katharina Tesch, Hassan Abolhassani, Bella Shadur, et al.
Frontiers in Immunology
|
October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology
|
September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia
Stefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Frontiers in Immunology
|
August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Experimental Medicine
|
July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines
Nicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.
The Journal of Allergy and Clinical Immunology
|
September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Isabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
Blood
|
April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival
Tanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
Science Immunology
|
June 17, 2018
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity
Vivien Béziat, Juan Li, Jian-Xin Lin, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 245) with videos related to
Sort By:
Page
of 25
Nature Medicine
|
February 15, 2024
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
Maddalena Migliavacca, Federica Barzaghi, Claudia Fossati, et al.
Journal of Clinical Immunology
|
July 29, 2021
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
Hasan Hashem, Giorgia Bucciol, Seza Ozen, et al.
The Journal of Allergy and Clinical Immunology
|
December 31, 2019
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Victoria Katharina Tesch, Hassan Abolhassani, Bella Shadur, et al.
Frontiers in Immunology
|
October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Journal of Clinical Immunology
|
September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-Telangiectasia
Stefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Frontiers in Immunology
|
August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin Content
Kerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
The Journal of Experimental Medicine
|
July 5, 2019
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines
Nicholas Hernandez, Giorgia Bucciol, Leen Moens, et al.
The Journal of Allergy and Clinical Immunology
|
September 27, 2020
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Isabelle Meyts, Giorgia Bucciol, Isabella Quinti, et al.
Blood
|
April 5, 2024
Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival
Tanja C Vallée, Jannik S Glasmacher, Hannes Buchner, et al.
Science Immunology
|
June 17, 2018
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity
Vivien Béziat, Juan Li, Jian-Xin Lin, et al.
Page
of 25